2024
Adherence to the ISHLT Protocol for the Referral of Patients with Idiopathic Pulmonary Fibrosis to the Transplantation Center among of Czech Centers for Interstitial Lung Diseases
STERCLOVA, Martina, Martina DOUBKOVÁ, Lubica SÝKOROVÁ, Vladimir BARTOS, Monika ZURKOVA et. al.Základní údaje
Originální název
Adherence to the ISHLT Protocol for the Referral of Patients with Idiopathic Pulmonary Fibrosis to the Transplantation Center among of Czech Centers for Interstitial Lung Diseases
Autoři
STERCLOVA, Martina (203 Česká republika), Martina DOUBKOVÁ (203 Česká republika), Lubica SÝKOROVÁ (703 Slovensko), Vladimir BARTOS (203 Česká republika), Monika ZURKOVA (203 Česká republika), Vladimira LOSTAKOVA (203 Česká republika), Radka MOKOSOVA (203 Česká republika), Martina PLACKOVA (203 Česká republika), Ladislav LACINA (203 Česká republika), Michaela CIMROVA (203 Česká republika), Radka BITTENGLOVA (203 Česká republika), Pavlina LISA (203 Česká republika), Pavla MUSILOVA (203 Česká republika), Daniel DOLEZAL (203 Česká republika), Jana PSIKALOVA (203 Česká republika), Petra OVESNÁ (203 Česká republika, domácí) a Martina VASAKOVA KOZIAR (203 Česká republika)
Vydání
PULMONARY MEDICINE, LONDON, HINDAWI LTD, 2024, 2090-1836
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30203 Respiratory systems
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.300 v roce 2022
Organizační jednotka
Lékařská fakulta
UT WoS
001264811300001
Klíčová slova anglicky
Idiopathic Pulmonary Fibrosis; ISHLT Protocol
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 15. 8. 2024 10:32, Mgr. Tereza Miškechová
Anotace
V originále
There are limited data on referral rates and the number of patients with idiopathic pulmonary fibrosis (IPF) who are eligible for lung transplantation. The aim of the present study was to assess adherence to the consensus of the International Society for Heart and Lung Transplantation (ISHLT) for the referral of patients with IPF among Czech interstitial lung disease (ILD) centers. Czech patients who were diagnosed with IPF between 1999 and 2021 (n=1584) and who were less than 65 years old at the time of diagnosis were retrospectively selected from the Czech Republic of the European Multipartner Idiopathic Pulmonary Fibrosis Registry (EMPIRE). Nonsmokers and ex-smokers with a body mass index (BMI) of <32 kg/m2 (n=404) were included for further analyses. Patients with a history of cancer <5 years from the time of IPF diagnosis, patients with alcohol abuse, and patients with an accumulation of vascular comorbidities were excluded. The trajectory of individual patients was verified at the relevant ILD center. From the database of transplant patients (1999-12/2021, n=541), all patients who underwent transplantation for pulmonary fibrosis (n=186) were selected, and the diagnosis of IPF was subsequently verified from the patient's medical records (n=67). A total of 304 IPF patients were eligible for lung transplantation. Ninety-six patients were referred to the transplant center, 50% (n=49) of whom were referred for lung transplantation. Thirty percent of potentially eligible patients not referred to the transplant center were considered to have too many comorbidities by the reporting physician, 19% of IPF patients denied lung transplantation, and 17% were not referred due to age. Among Czech patients with IPF, there may be a larger pool of potential lung transplant candidates than has been reported to the transplant center to date.